Renal Insufficiency Clinical Trials

14 recruiting

Renal Insufficiency Trials at a Glance

43 actively recruiting trials for renal insufficiency are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 16 trials, with the heaviest enrollment activity in Boston, Shanghai, and Beijing. Lead sponsors running renal insufficiency studies include Centre Hospitalier Universitaire de Nīmes, Hospices Civils de Lyon, and Bayer.

Browse renal insufficiency trials by phase

Treatments under study

About Renal Insufficiency Clinical Trials

Looking for clinical trials for Renal Insufficiency? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Renal Insufficiency trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Renal Insufficiency clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 43 trials

Recruiting

Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion

Primary AldosteronismAdrenal InsufficiencyAutonomous Cortisol Secretion
Qifu Li521 enrolled1 locationNCT06955286
Recruiting

Evaluation of Children With Endocrine and Metabolic-Related Conditions

Metabolic DiseaseAdrenal InsufficiencyBone Diseases, Metabolic+2 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)15,000 enrolled1 locationNCT02769975
Recruiting
Not Applicable

A Methodological Study to Learn More About Kidney Function in Healthy People and in People With Reduced Kidney Function

Acute Kidney Injury, Renal Insufficiency
Bayer50 enrolled1 locationNCT07368712
Recruiting
Not Applicable

AI-Guided Relaxation for Hemodialysis Anxiety

AnxietyMaintenance HemodialysisStress, Psychological+2 more
Alexandria University60 enrolled2 locationsNCT07522944
Recruiting

Kidney Precision Medicine Project

Chronic Kidney DiseasesType 1 Diabetes (T1D)Kidney Failure, Acute+12 more
Icahn School of Medicine at Mount Sinai1,000 enrolled13 locationsNCT04334707
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 4

Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency

Adrenal InsufficiencyGiant Cell ArteritisPolymyalgia Rheumatica
Marianne Christina Klose250 enrolled3 locationsNCT05435781
Recruiting
Phase 1

A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function

Renal Insufficiency
Eli Lilly and Company32 enrolled4 locationsNCT07137689
Recruiting
Not Applicable

Exercise During Hemodialysis: Impact on Sarcopenia and Sleep Quality

SarcopeniaRenal Insufficiency, Chronic
University of Salamanca58 enrolled1 locationNCT07447375
Recruiting

Transformative Research in Diabetic Nephropathy 2.0

Diabetes Mellitus, Type 2Kidney DiseasesDiabetic Nephropathies+1 more
University of Pennsylvania200 enrolled1 locationNCT07444203
Recruiting
Not Applicable

Updated Diagnostic Cortisol Values for Adrenal Insufficiency

Adrenal Insufficiency
Montefiore Medical Center90 enrolled1 locationNCT05149638
Recruiting
Not Applicable

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

Chronic Kidney DiseasesArteriovenous FistulaVascular Access Complication+7 more
VenoStent600 enrolled28 locationsNCT06001827
Recruiting
Not Applicable

Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.

Renal Insufficiency, Chronic
Hospices Civils de Lyon60 enrolled1 locationNCT06047106
Recruiting
Not Applicable

Food Frequency Questionnaire to Assess Sodium Intake

HypertensionRenal Insufficiency
University Hospital, Lille99 enrolled1 locationNCT05533645
Recruiting
Phase 4

Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment

Adrenal InsufficiencyGiant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
Marianne Andersen100 enrolled3 locationsNCT05193396
Recruiting

Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment

Liver TransplantationRenal Insufficiency, Chronic
RenJi Hospital369 enrolled2 locationsNCT05326399
Recruiting
Not Applicable

Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients

Renal Insufficiency
CHU de Reims302 enrolled1 locationNCT05117450
Recruiting
Not Applicable

Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Care (NI-AKI)

Acute Renal InsufficiencyNAD
Ramsay Générale de Santé150 enrolled1 locationNCT07203131
Recruiting

Establishment and Clinical Application of Reference Intervals of Salivary Cortisol

Cushing SyndromeAdrenal InsufficiencyHealthy Adult
Shanghai 6th People's Hospital220 enrolled1 locationNCT07168122
Recruiting
Not Applicable

DIALysis With EXpanded Solute Removal

Kidney DiseaseChronic Kidney Disease Requiring HemodialysisHemodialysis+5 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's4,800 enrolled1 locationNCT06660277